Amniotic Therapies

Amniotic Therapies is a biotechnology company focused on developing regenerative medicine products derived from human amniotic fluid. The company's primary focus is on utilizing the unique properties of amniotic fluid-derived stem cells and growth factors to treat orthopedic conditions, such as osteoarthritis, and to enhance wound healing. By leveraging a proprietary collection and processing platform, Amniotic Therapies aims to provide minimally invasive, off-the-shelf therapeutic solutions that promote tissue repair and reduce inflammation. The company was founded to translate academic research into clinical applications for regenerative therapy.